Worldwide Clinical Trials Balances Experience with Innovation

Anxiety disorders comprise a number of psychiatric conditions, most commonly generalized by anxiety disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and social phobia. The diagnosis of anxiety disorders involves both physical and psychological investigation. The implications of anxiety disorders on the health care system are significant, because people with anxiety disorder are more likely to be hospitalized or seek a doctor’s attention for psychiatric treatment than those who do not have an anxiety disorder. Comorbid conditions, such as depression, are common for people with anxiety disorders, adding to the complexity of the indication as a focus of research.

Worldwide Clinical Trials has been at the forefront of central nervous system disorders research for 30+years and continues to move the learning forward. Our previous studies in psychiatric indications have enriched our expertise in a broad range of clinical approaches, including self-reporting tools and cognitive assessment instruments. Our broad global reach gives us access to remote patient populations, as well as a familiarity with regulatory and cultural considerations related to psychiatric patient research in many geographic regions of the world.